Vascular pathology and repair in the aging heart: Alterations in inflammatory mediators

Drug Discovery Today: Disease Mechanisms

Volumn 1, Issue 1, 2004, Pages 59-64

  Edelberg, Jay M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

AGING; APOPTOSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENDOTHELIUM CELL; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SENESCENCE; STEM CELL;

EID: 23744503523     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2004.08.011     Document Type: Review

References (30)

1. National Institutes of Health, (2000) Morbidity & Mortality. 2000 Chart Book on Cardiovascular, Lung, and Blood Diseases. National Institutes of Health - National Heart, Lung, and Blood Institute, Washington, DC
2. Association, A.H. (2001) Americans and Cardiovascular Disease Biostatistical Fact Sheet - Older Americans and Cardiovascular Disease. American Heart Association, Dallas, TX
3. Widlansky, M.E. et al. (2003) The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol 42, 1149-1160
4. Cesari, M. et al. (2003) Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108, 2317-2322 (epub October 2003, 2320)
5. Bruunsgaard, H. et al. (2000) Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin. Exp. Immunol. 121, 255-260
6. Roubenoff, R. et al. (2003) Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am. J. Med. 115, 429-435
7. Nakano, M. et al. (1998) Tumor necrosis factor-alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte. Circulation 97, 1392-1400
8. Sivasubramanian, N. et al. (2001) Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104, 826-831
9. Bruunsgaard, H. et al. (1999) A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J. Gerontol. A Biol. Sci. Med. Sci. 54, M357-M364
10. Csiszar, A. et al. (2003) Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries. FASEB J. 17, 1183-1185 (epub April 2003, 1122)
11. Hoffmann, J. et al. (2001) TNFalpha and oxLDL reduce protein S-nitrosylation in endothelial cells. J. Biol. Chem. 276, 41383-41387
12. Mann, D.L. (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ. Res. 91, 988-998
13. Cai, D. et al. (2003) Age-associated impairment in TNF-{alpha} cardio-protection from myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 285, H463-H469
14. Kurrelmeyer, K.M. et al. (2000) Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc. Natl. Acad. Sci. USA 97, 5456-5461
15. Edelberg, J.M. et al. (2002) Platelet-derived growth factor-AB limits the extent of myocardial infarction in a rat model: feasibility of restoring impaired angiogenic capacity in the aging heart. Circulation 105, 608-613
16. Rivard, A. et al. (1999) Age-dependent impairment of angiogenesis. Circulation 99, 111-120
17. Xaymardan, M. et al. (2004) Senescent impairment in synergistic cytokine pathways that provide rapid cardioprotection in the rat heart. J. Exp. Med. 199, 797-804
18. Hill, J.M. et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348, 593-600
19. Vasa, M. et al. (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89, E1-E7
20. Rauscher, F.M. et al. (2003) Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108, 457-463 (epub July 2003, 2014)
21. Edelberg, J.M. et al. (2002) Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ. Res. 90, E89-E93
22. Edelberg, J.M. et al. (1998) PDGF mediates cardiac microvascular communication. J. Clin. Invest. 102, 837-843
23. Orlic, D. et al. (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA 98, 10344-10349
24. Badorff, C. et al. (2003) Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107, 1024-1032
25. Xaymardan, M. et al. (2004) Platelet-derived growth factor-AB promotes the generation of adult bone marrow-derived cardiac myocytes. Circ. Res. 94, E39-E45
26. Torella, D. et al. (2004) Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ. Res. 94, 514-524 (epub January 2004, 2015)
27. Chung, E.S. et al. (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 107, 3133-3140
28. Sliwa, K. et al. (1998) Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet 351, 1091-1093
29. Sliwa, K. et al. (2004) Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study. Circulation 109, 750-755
30. Vasa, M. et al. (2001) Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103, 2885-2890